Immunome, Inc. (IMNM) Net income 2019–2025
Immunome, Inc. (IMNM) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$212.4MFY2025 · since FY2019: -$10.4M → -$212.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$212.4M | +27.5% |
| FY2024 | -$293.0M | -174.3% |
| FY2023 | -$106.8M | -189.5% |
| FY2022 | -$36.9M | -49.3% |
| FY2021 | -$24.7M | -38.5% |
| FY2020 | -$17.8M | -70.8% |
| FY2019 | -$10.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice